Taro Pharmaceutical Industries Ltd.
TARO
TARO was delisted on the 21st of June, 2024.
153 hedge funds and large institutions have $910M invested in Taro Pharmaceutical Industries Ltd. in 2015 Q4 according to their latest regulatory filings, with 50 funds opening new positions, 48 increasing their positions, 37 reducing their positions, and 17 closing their positions.
194% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 17
30% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 37
28% more capital invested
Capital invested by funds: $708M → $910M (+$201M)
26% more funds holding
Funds holding: 121 → 153 (+32)
14% more call options, than puts
Call options by funds: $6.41M | Put options by funds: $5.59M
13% more funds holding in top 10
Funds holding in top 10: 8 → 9 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$21.6M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$20.4M |
| 3 |
FCH
Freestone Capital Holdings
Seattle,
Washington
|
+$16.2M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$14M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$13.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIM
Freedom Investment Management
Hartford,
Connecticut
|
-$28.6M |
| 2 |
ICM
ISZO Capital Management
New York
|
-$25.9M |
| 3 |
MCP
Moab Capital Partners
Southampton,
New York
|
-$11.8M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.53M |
| 5 |
MICM
Matthews International Capital Management
San Francisco,
California
|
-$5.32M |
TARO Hedge Fund Activity: Q4 2015 in Review
153 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q4 2015, worth a combined $910M — up 28% from $708M a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new TARO positions and 17 closed out — a net gain of 33 holders — while 48 added to existing stakes and 37 trimmed.
The largest buyer was Goldman Sachs, adding an estimated $21.6M. The largest seller was Freedom Investment Management, cutting an estimated $28.6M.
- 153 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q4 2015, up from 121 in Q3 2015.
- Funds reported $910M of Taro Pharmaceutical Industries Ltd. stock for Q4 2015, up 28% quarter-over-quarter.
- 50 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q4 2015 and 17 closed out, a net change of +33 holders.
- The largest Taro Pharmaceutical Industries Ltd. buyer in Q4 2015 was Goldman Sachs, an estimated $21.6M added.
- The largest Taro Pharmaceutical Industries Ltd. seller in Q4 2015 was Freedom Investment Management, an estimated $28.6M sold.
Based on aggregated 13F filings for Q4 2015.